Welgene Biotech Co.,Ltd.

NT$16.15As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6661Healthcare
Country Taiwan
PE (Fwd) •••
TSR 9Y CAGR (1.93%)
Div yield —
ROE (0.49%)
Diagnostics & Research
Beta (5Y) 0.18
PE TTM —
TSR TTM (14.78%)
Mkt cap NT$376.4M
ROIC (0.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$17
2.42%
(4.47%)
Hold 11|5|4|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.15
0.14
0.14
0.15
12.40%
13.46%
1.20%
1.94%
RevenueNT$M
21.87
22.32
22.26
22.10
1.68%
5.84%
2.91%
0.15%
Peers (US$11.37M)
Cap (US$)
PE
21.39M
102.4x
12.27M
—
Capital
TTM
5Y
10Y
Leveragex
0.218
0.128
0.123
EBIT/Intx
0.119
0.418
0.451
Own earn%
74.77
(53.28)
(78.24)
Sh yield%
32.65
23.12
22.96
Owners
Insiders/Inst%
10.87
78.67
Short interest%
1.45
SBC / revenue%
1.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
31–35
$1 testx
0.0
Incr. ROIC%
7